We found that the plasma levels of caspase-cleaved K18 (ccK18) were significantly increased when sampled 72 hours after doxorubicin treatment as compared to untreated tumor-bearing mice (p = 0.0007, Fig. 4A). This evidence concerns the gene KRT18 and neoplasm.